KamRAB - HRIG
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedAbout KamRAB - HRIG
KamRAB - HRIG is a phase 3 stage product being developed by Kamada for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT02912845. Target conditions include Rabies.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02912845 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies